Literature DB >> 16572352

Oligonucleotide-polyethylenimine complexes targeting retinal cells: structural analysis and application to anti-TGFbeta-2 therapy.

Ana L Gomes dos Santos1, Amélie Bochot, Nicolas Tsapis, Franck Artzner, Riad Antoine Bejjani, Brigitte Thillaye-Goldenberg, Yvonne de Kozak, Elias Fattal, Francine Behar-Cohen.   

Abstract

PURPOSE: The aim of this study was to characterize oligonucleotide-polyethylenimine (ODN/PEI) complex preparation for potential transfection of retinal cells in vitro and in vivo.
METHODS: The effect of medium preparation [HEPES-buffered saline (HBS), water] on particle size and morphology was evaluated. Cultured Lewis rat retinal Müller glial (RMG) cells were transfected using fluorescein isothiocyanate (FITC)-ODN/PEI complexes specifically directed at transforming growth factor beta (TGFbeta)-2. Efficacy of transfection was evaluated using confocal microscopy, and regulation of gene expression was assayed using quantitative real-time RT-PCR and ELISA assay. One, 24, and 72 h after injection of FITC-ODN/PEI complexes into the vitreous of rat eyes, their distribution was analyzed on eye sections.
RESULTS: Complexes prepared in HBS were smaller than complexes prepared in pure water and presented a core-shell structure. These particles showed a high cellular internalization efficacy, along with a significant and specific down-regulation of TGFbeta-2 expression and production in RMG cells, correlating with specific inhibition of cell growth at 72 h. In vivo, complexes efficiently transfect retinal cells and follow a transretinal migration at 24 h. After 72 h, ODN seems to preferentially target RMG cells without inducing any detectable toxicity.
CONCLUSIONS: Specific down-regulation of TGFbeta-2 expression using ODN/PEI complexes may have potential interest for the treatment of retinal diseases associated with glial proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572352     DOI: 10.1007/s11095-006-9748-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  34 in total

Review 1.  DNA nanoparticles and development of DNA delivery vehicles for gene therapy.

Authors:  Veena Vijayanathan; Thresia Thomas; T J Thomas
Journal:  Biochemistry       Date:  2002-12-03       Impact factor: 3.162

2.  Antisense oligonucleotide therapeutics.

Authors:  C F Bennett
Journal:  Expert Opin Investig Drugs       Date:  1999-03       Impact factor: 6.206

Review 3.  DNA condensation by multivalent cations.

Authors:  V A Bloomfield
Journal:  Biopolymers       Date:  1997       Impact factor: 2.505

4.  A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.

Authors:  J G Lewis; K Y Lin; A Kothavale; W M Flanagan; M D Matteucci; R B DePrince; R A Mook; R W Hendren; R W Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  Ionic and structural specificity effects of natural and synthetic polyamines on the aggregation and resolubilization of single-, double-, and triple-stranded DNA.

Authors:  M Saminathan; T Antony; A Shirahata; L H Sigal; T Thomas; T J Thomas
Journal:  Biochemistry       Date:  1999-03-23       Impact factor: 3.162

Review 6.  Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.

Authors:  R M Orr
Journal:  Curr Opin Mol Ther       Date:  2001-06

7.  A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides.

Authors:  I Jääskeläinen; S Peltola; P Honkakoski; J Mönkkönen; A Urtti
Journal:  Eur J Pharm Sci       Date:  2000-05       Impact factor: 4.384

8.  Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum.

Authors:  S Capaccioli; G Di Pasquale; E Mini; T Mazzei; A Quattrone
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

9.  Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides.

Authors:  A Bochot; E Fattal; A Gulik; G Couarraze; P Couvreur
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

10.  Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.

Authors:  M F Cordeiro; A Mead; R R Ali; R A Alexander; S Murray; C Chen; C York-Defalco; N M Dean; G S Schultz; P T Khaw
Journal:  Gene Ther       Date:  2003-01       Impact factor: 5.250

View more
  9 in total

Review 1.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

2.  Ventral mesencephalon astrocytes are more efficient than those of other regions in inducing dopaminergic neurons through higher expression level of TGF-beta3.

Authors:  Kairong Li; Bing Xue; Yue Wang; Xuan Wang; Haomin Wang; Xiaomin Wang
Journal:  J Mol Neurosci       Date:  2008-11-04       Impact factor: 3.444

Review 3.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

Review 4.  Nanoparticle-motivated gene delivery for ophthalmic application.

Authors:  Rajendra Narayan Mitra; Min Zheng; Zongchao Han
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-06-22

Review 5.  A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.

Authors:  Adarsha Koirala; Shannon M Conley; Muna I Naash
Journal:  Biomaterials       Date:  2013-06-22       Impact factor: 12.479

Review 6.  Polymeric vectors for ocular gene delivery.

Authors:  Viral Tamboli; Gyan P Mishra; Ashim K Mitrat
Journal:  Ther Deliv       Date:  2011-04

7.  Modulation of TGFβ(2) and dopamine by PKC in retinal Müller cells of guinea pig myopic eye.

Authors:  Jun-Feng Mao; Shuang-Zhen Liu; Wen-Juan Qin; Qian Xiang
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

8.  Lipid nanoparticles for delivery of messenger RNA to the back of the eye.

Authors:  Siddharth Patel; Renee C Ryals; Kyle K Weller; Mark E Pennesi; Gaurav Sahay
Journal:  J Control Release       Date:  2019-04-12       Impact factor: 9.776

Review 9.  Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties.

Authors:  Giuseppe De Rosa; Maria Immacolata La Rotonda
Journal:  Molecules       Date:  2009-07-29       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.